Medicover AB (MCOVb)

Currency in SEK
256.5000
-2.5000(-0.97%)
Closed·
MCOVb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
255.0000259.0000
52 wk Range
179.4000284.5000
Key Statistics
Prev. Close
259
Open
256
Day's Range
255-259
52 wk Range
179.4-284.5
Volume
37.14K
Average Volume (3m)
71.42K
1-Year Change
12.5%
Book Value / Share
40.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MCOVb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
287.6818
Upside
+12.16%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Medicover AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 287.6818
(+12.16% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold238.00-7.21%220.00Maintain10-08-2026

Medicover AB Earnings Call Summary for Q3/2026

  • Medicover Q3 EPS of EUR 0.16 missed forecast of $0.1732 by 7.6%; shares fell 2.9% to $268 despite 8% organic revenue growth and 22% EBIT increase.
  • Company achieved seventh consecutive quarter of margin improvement with EBIT margin up 110 bps and adjusted EBITDA margin rising to 17.8% from 17.6%.
  • India business sale expected to generate EUR 740M for 66.1% stake, closing November 2026, leaving Medicover near debt-free with leverage at 2.7x.
  • Near-term headwinds include German genetics reimbursement changes, 4% Romania membership decline, and facility restructuring affecting 118 closures vs 140 openings.
  • Management maintains full-year CapEx guidance at 6-6.5% of revenue; prioritizes India deal closure before capital allocation decisions on M&A and expansion.
Last Updated: 04-11-2026, 03:04 pm
Read Full Transcript

Earnings

Latest Release
04-11-2026
EPS / Forecast
0.16 / 0.17
Revenue / Forecast
570.8M / 639.13M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.71
Dividend Yield
0.85%
Industry Median 1.09%
Annualised payout
2.17
Paid annually
5-Years Growth
+23.36%
Growth Streak

MCOVb Income Statement

Compare MCOVb to Peers and Sector

Metrics to compare
MCOVb
Peers
Sector
Relationship
P/E Ratio
38.8x19.1x−0.2x
PEG Ratio
0.940.970.00
Price/Book
6.4x2.5x2.6x
Price / LTM Sales
1.4x0.6x2.6x
Upside (Analyst Target)
12.2%41.1%76.9%
Fair Value Upside
Unlock19.3%14.9%Unlock

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Employees
49000
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
18.36M12.08%4.75B
Other Institutional Investors
98.88M65.06%25.61B
Public Companies & Retail Investors
34.74M22.86%9.00B
Total
151.97M100.00%39.36B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celox Holding AB31.03%4,71,57,3651,22,13,758
Estate Of Jonas Af Jochnick13.02%1,97,79,93551,23,003

FAQ

What Is the Medicover (MCOVb) Share Price Today?

The Medicover share price today is 256.5000.

What is the current Medicover (MCOVb) share price and day range?

As of 21-11-2026, the Medicover share price is 256.5000, with a previous close of 259.0000. The share price has ranged from 255.0000 to 259.0000 today, while the 52-week range spans from 179.4000 to 284.5000.

What Is the Medicover Market Cap?

As of today, Medicover market cap is 38.9800B.

Does Medicover Pay Dividends? What's The Current Dividend Yield?

The Medicover dividend yield is 0.8%%.

What Is the Medicover (MCOVb) Share Price Target?

The average 12-month share price target for Medicover is 287.6818, with a high estimate of 347.06284843 and a low estimate of 243.47455441. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +12.16% Upside potential.

What Is Medicover's Earnings Per Share (TTM)?

The Medicover EPS (TTM) is 6.71.

When Is the Next Medicover Earnings Date?

Medicover will release its next earnings report on 10-02-2027.

From a Technical Analysis Perspective, Is MCOVb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Medicover Trade On?

Medicover is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Medicover?

The stock symbol for Medicover is "MCOVb."

How Many Times Has Medicover Stock Split?

Medicover has split 0 times.

How Many Employees Does Medicover Have?

Medicover has 49000 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.